Reveal Surgical

Reveal Surgical, formerly known as ODS Medical, is a Montreal-based medical technology company developing AI-enabled tissue characterization tools for use during surgery. Its lead product, the Sentry system, combines Raman spectroscopy, optical probes, and machine learning to help surgeons identify cancerous tissue in vivo and in real time. The company has focused initially on neurosurgical applications, especially brain tumor resection, with supporting clinical studies in glioblastoma, brain metastases, and meningioma. Reveal positions its technology as a broader tumor-detection platform that could expand into additional cancer indications and surgical settings. The company is private and appears to remain independent.